2m 2m 2m 2m 2m 2m 2m
TREVI THERAPEUTI (TRVI)
NASDAQ
$17.96$0.00 (0.00%)
Price as of Aug 21, 2026 7:30 PM EDT- $2.6BMarket Cap
- 137.88%1-Year Change
- BiotechnologyIndustry
TREVI THERAPEUTI (TRVI)
$17.96$0.00 (0.00%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
NEA MANAGEMENT COMPANY, LLC | 9.31% | 13.2M | 0 (0.00%) | Jun 30, 2026 |
FMR LLC | 8.85% | 12.6M | +4.5M (+36.02%) | Jun 30, 2026 |
BLACKROCK, INC. | 7.86% | 11.2M | +914,840 (+8.20%) | Jun 30, 2026 |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 7.00% | 9.9M | -100 (-0.001%) | Jun 30, 2026 |
VANGUARD GROUP INC | 4.53% | 6.4M | +607,669 (+9.44%) | Dec 31, 2025 |
WELLINGTON MANAGEMENT GROUP LLP | 4.00% | 5.7M | +495,504 (+8.72%) | Jun 30, 2026 |
VANGUARD CAPITAL MANAGEMENT LLC | 3.90% | 5.5M | +552,108 (+9.98%) | Jun 30, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 3.42% | 4.9M | +310,911 (+6.40%) | Mar 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 2.38% | 3.4M | +86,300 (+2.56%) | May 31, 2026 |
FIDELITY SECURITIES FUND | 2.07% | 2.9M | +1.0M (+34.24%) | Apr 30, 2026 |
MUTUAL FUND SERIES TRUST | 1.86% | 2.6M | +1,303 (+0.05%) | Mar 31, 2026 |
FIDELITY MT VERNON STREET TRUST | 1.08% | 1.5M | +970,848 (+63.20%) | May 31, 2026 |
AB CAP FUND, INC. | 0.84% | 1.2M | -120,197 (-10.02%) | Apr 30, 2026 |
FIDELITY CONCORD STREET TRUST | 0.76% | 1.1M | +102,457 (+9.52%) | May 31, 2026 |
Current Ownership Distribution
- Institutions1.3B (85.88%)
- Mutual Funds178.3M (11.50%)
- Insiders40.6M (2.62%)
- Other0 (0.00%)
Insider Transactions
- 2.62% (40.6M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 0Number of InsiderSelling (last 12 months)
- $0.00Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
SCIASCIA THOMAS Chief Scientific Officer | Award | Feb 19, 2026 | $0.00 | 85,000 | $0.00 | 85,000 |
Simon Farrell Chief Commercial Officer | Award | Feb 19, 2026 | $0.00 | 160,000 | $0.00 | 160,000 |
Galletta Christopher See Remarks | Award | Feb 19, 2026 | $0.00 | 35,000 | $0.00 | 35,000 |
GOOD JENNIFER L President & CEO | Award | Feb 19, 2026 | $0.00 | 675,000 | $0.00 | 675,000 |
HASTINGS DAVID C Chief Financial Officer | Award | Jan 08, 2026 | $0.00 | 375,000 | $0.00 | 375,000 |
Colangelo Dominick | Award | Jun 11, 2025 | $0.00 | 45,000 | $0.00 | 45,000 |
Heffernan Michael Thomas | Award | Jun 11, 2025 | $0.00 | 45,000 | $0.00 | 45,000 |
VANLENT ANNE | Award | Jun 11, 2025 | $0.00 | 45,000 | $0.00 | 45,000 |
Meeker David P | Award | Jun 11, 2025 | $0.00 | 45,000 | $0.00 | 45,000 |
Mathers Edward T | Award | Jun 11, 2025 | $0.00 | 45,000 | $0.00 | 45,000 |
SCIASCIA THOMAS Chief Scientific Officer | Award | May 31, 2025 | $0.00 | 60,000 | $0.00 | 92,000 |
GOOD JENNIFER L President & CEO | Award | May 31, 2025 | $0.00 | 102,000 | $0.00 | 156,400 |
Delfini Lisa Chief Financial Officer | Award | May 31, 2025 | $0.00 | 72,000 | $0.00 | 110,400 |
Simon Farrell Chief Commercial Officer | Award | May 31, 2025 | $0.00 | 72,000 | $0.00 | 110,400 |
Galletta Christopher See Remarks | Award | May 31, 2025 | $0.00 | 8,550 | $0.00 | 13,110 |
Walker Paul Edward | In The Money | Apr 17, 2025 | $0.00 | 1.9M | $0.00 | 0 |
New Enterprise Associates 16, L.P. | In The Money | Apr 17, 2025 | $0.00 | 1.9M | $0.00 | 0 |
Makhzoumi Mohamad | In The Money | Apr 17, 2025 | $0.00 | 1.9M | $0.00 | 0 |
New Enterprise Associates 16, L.P. | In The Money | Apr 17, 2025 | $2.5M | 1.9M | $1.37 | 12.3M |
Walker Paul Edward | In The Money | Apr 17, 2025 | $2.5M | 1.9M | $1.37 | 12.3M |
Makhzoumi Mohamad | In The Money | Apr 17, 2025 | $2.5M | 1.9M | $1.37 | 12.3M |
SCIASCIA THOMAS Chief Scientific Officer | Exempt | Mar 25, 2025 | $0.00 | 2,631 | $0.00 | 0 |
SCIASCIA THOMAS Chief Scientific Officer | Exempt | Mar 25, 2025 | $3,762.33 | 2,631 | $1.43 | 224,004 |
SCIASCIA THOMAS Chief Scientific Officer | Sell | Mar 25, 2025 | $17,364.60 | 2,631 | $6.60 | 221,373 |
GOOD JENNIFER L President & CEO | Exempt | Mar 21, 2025 | $0.00 | 5,263 | $0.00 | 0 |
GOOD JENNIFER L President & CEO | Exempt | Mar 21, 2025 | $7,526.09 | 5,263 | $1.43 | 218,576 |
GOOD JENNIFER L President & CEO | Sell | Mar 21, 2025 | $34,624.75 | 5,263 | $6.58 | 213,313 |
Simon Farrell Chief Commercial Officer | Award | Mar 10, 2025 | $0.00 | 38,400 | $0.00 | 38,400 |
Delfini Lisa Chief Financial Officer | Award | Mar 10, 2025 | $0.00 | 38,400 | $0.00 | 38,400 |
GOOD JENNIFER L President & CEO | Award | Mar 10, 2025 | $0.00 | 54,400 | $0.00 | 54,400 |